Novo Nordisk announced that the European Medicines Agency (EMA) has approved an update to the label for Rybelsus (oral ...

Cadrenal Therapeutics has acquired eXIthera Pharmaceuticals' portfolio of Factor XIa inhibitors to expand its anticoagulation ...

Annual Meeting 2025, held from August 29 to September 1 in Madrid, Spain, showcased a sweeping array of advancements in the cardiovascular and metabolic disorders (CVMD) space, with 7,804 total ...

Despite missing the primary endpoint, aTyr Pharma still sees a future for the drug as it plans further FDA discussions.

The deal marks the second time Novartis has tapped Monte Rosa’s services in just under year. The US big pharma company paid ...

US-based Amneal Pharmaceuticals has secured approval from the FDA for its 500mg/mL sodium oxybate oral solution.

FDA chief Martin Makary said the agency will now ‘proactively monitor’ pharma companies for advertising law breaches.

AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, according to reports from ...

Kriya Therapeutics has closed an oversubscribed Series D funding round, raising $320m, aimed at propelling its gene therapy ...

The demand for small-scale fill-finish services is rapidly expanding as the pharmaceutical industry shifts toward more ...

Zentiva, a Czech producer of generic medications, is poised for a change in ownership as Advent has agreed to sell the ...

Kashiv BioSciences has entered a partnership with Brazilian biopharmaceutical company CRISTÁLIA to facilitate the marketing ...